Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Migration of unmigrated content due to installation of a new plugin
Tuesday
 To do's
To Do's
  •  Gel for oligo annealing
  •  Mix new annealing buffer
  •  Anneal oligos
  •  Design IgM Sequencing Primers
  •  CD79B, gal4 PCR
  •  Golden Gates:
    •  hEF1a:CD79B-pTET:mRFP-Gal4 golden gate
    •  TRE:Syk-15-tTEVp
  •  Transform
    •  hEF1a:CD79B-pTET:mRFP-Gal4 GG
    •  TRE:Syk-15-tTEVp GG
  •  TRE:Syk-pTET:mRFP-tTEVp sequencing 
  •  Pick pENTR RFP-IgM Colony
Wednesday's to Dos
  •  rePCR Gal4, CD79B
  •  Gel PCRs
  •  GG hEF1a:CD79B-pTet:RFP-Gal4VP16
  •  Transform hEF1a:CD79B-pTet:RFP-Gal4VP16
Thursday's to Dos
  •  Review Syk-RFP-tTEV Cloning (rePCR?)(Used wrong RFP for GG?) 
  •  hEF1a:Gal4 pick new colony
  •  pick hEF1a:CD79B-RFP-Gal4VP16 colonies (no red colonies present)
  •  pick pENTR RFP-IgM Colonies
  •  Innoculate midis of CDA linker 
  •  Pick colonies of failed CDA linker constructs
  •  Analyze TRE:Syk-pTet:RFP-tTEV Sequencing
  •  Resend correct TRE:Syk-pTet:RFP-tTEV for sequencing
Friday's to Dos
  •  inoculate cd79a 15t3 midi
:
  •  Midiprep (from freezer)
    •  S9TEV
    •  B15T15
  •  Golden Gate
    •  B9T9
    •  B15T9
  •  LR
    •  hEF1a-CuO:Gmab H
    •  hEF1a-CuO:Gmab L
    •  hEF1a-CuO:CD79A
    •  hEF1a-CuO:CD79B
    •  hEF1a-CuO:Lyn
  •  Digest all of the Syk-TEVp and Syk-tTEVp midis just to be sure (since there's an internal cut site that didn't get read in sequencing)



Sequencing account information:
^^^Email: bcrpeeps@mit.edu

^^^Pass: grapefruit

 

 

## Digest tTEVp and TEVp midis just to be sure (since there's an internal cut site)

Non-Lab To Do's 
  •  Cytometry time 
  •  Order Cumate 
  •  Chicken lysozyme, gp120
  •  Antibodies for antigen binding detection
Waiting on primers to do list:
  •  RFP-IgM sequencing 
  • Bug Brian about ordering antibody testing supplies
Higher Level To Do's:
  •  Decide on other antigen-variable regions we want to test  
  •  Is gantenerumab proprietary and can we actually publish with it?